Recursion Pharmaceuticals, Inc. · NASDAQ:RXRX

Dar Zavain received 5,109 Recursion Pharmaceuticals, Inc. shares as an award (Form 4)

Traded Jul 1, 2026 · Filed Jul 2, 2026

On Jul 1, 2026, Dar Zavain (Director) received 5,109 Recursion Pharmaceuticals, Inc. shares as an award, leaving 240,764 shares. Filed Jul 2, 2026 (Form 4).

Awarded
5,109 shares
Holding after
240,764 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 1, 2026Class A Common StockAward5,109240,764Direct

Source

View original at SEC

Related